|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 10-14-2004
NEW YORK (Reuters Health) - Although it's rare, children can develop heart enlargement and heart failure, which ultimately makes a heart transplant necessary. Now, researchers report that treatment with synthetic human growth hormone appears to benefit such children.
NEW YORK (Reuters Health) - Older patients with heart failure have a two-fold higher rate of mortality and re-admission after undergoing non-cardiac surgery than other patients in their age group, a Duke University research team reports.
NEW YORK (Reuters Health) - Older women who undergo surgery for breast cancer often worry about their appearance afterward, and getting the treatment that best meets these concerns may improve their long-term well-being, according to a new study.
NEW YORK (Reuters Health) - Weight-loss surgery for severe obesity may carry the risk of damage to the network of nerves that runs throughout the body, researchers reported Thursday.
STOCKHOLM (Reuters) - Ten or more years of mobile phone use increases the risk of developing acoustic neuroma, a benign tumor on the auditory nerve, according to a study released on Wednesday by Sweden's Karolinska Institute.
BOSTON (Reuters) - A study of more than 117,000 Danish women provides the most convincing evidence yet of a link between a girl's growth rate and her risk of developing breast cancer later in life, researchers said on Wednesday.
WASHINGTON (Reuters) - A computer chip that is implanted under the skin won U.S. approval on Wednesday for use in helping doctors quickly access a patient's medical history.
WASHINGTON (Reuters) - A new study will look at the brains of Alzheimer's patients to see if various scans can chart the disease and if new drugs can slow it down, doctors said on Wednesday.
BOSTON (Reuters) - A cutting-edge way of repairing dangerously enlarged blood vessels in the belly is better than the traditional treatment, Dutch doctors said on Wednesday, but a U.S. doctor immediately called the finding premature and possibly wrong.
WASHINGTON (Reuters) - Harvard University researchers said on Wednesday they were seeking permission to use cloning technology to make human stem cells.
|
|
